Literature DB >> 27142613

Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".

Rene Baudrand1, Luminita Pojoga2, Anand Vaidya2, Amanda Garza2, Paul Vöhringer3, Xavier Jeunemaitre4, Paul Hopkins5, Tham Yao2, Jonathan Williams2, Gail Adler2, Gordon Williams2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27142613      PMCID： PMC4862598          DOI： 10.1161/CIRCULATIONAHA.116.021486

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials.

Authors:  Amirhossein Sahebkar; Jana Rathouska; Luis E Simental-Mendía; Petr Nachtigal
Journal:  Pharmacol Res       Date:  2015-11-04       Impact factor: 7.658

2.  Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial.

Authors:  David A Calhoun; William B White; Henry Krum; Weinong Guo; Georgina Bermann; Angelo Trapani; Martin P Lefkowitz; Joël Ménard
Journal:  Circulation       Date:  2011-10-10       Impact factor: 29.690

3.  Lipophilic Statins and Aldosterone Secretion: A Bridge Too Far?

Authors:  Charlotte Andersson; Ramachandran S Vasan
Journal:  Circulation       Date:  2015-10-02       Impact factor: 29.690

4.  Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects.

Authors:  Rene Baudrand; Luminita H Pojoga; Anand Vaidya; Amanda E Garza; Paul A Vöhringer; Xavier Jeunemaitre; Paul N Hopkins; Tham M Yao; Jonathan Williams; Gail K Adler; Gordon H Williams
Journal:  Circulation       Date:  2015-10-02       Impact factor: 29.690

5.  Effect of very low LDL-cholesterol on cortisol synthesis.

Authors:  K Sezer; R Emral; D Corapcioglu; R Gen; E Akbay
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.